Compare BHM & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BHM | RPID |
|---|---|---|
| Founded | 2022 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 34.7M |
| IPO Year | 2022 | 2021 |
| Metric | BHM | RPID |
|---|---|---|
| Price | $7.26 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 3.3K | ★ 145.1K |
| Earning Date | 01-01-0001 | 11-17-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,734,000.00 | $33,587,000.00 |
| Revenue This Year | $1.31 | $16.95 |
| Revenue Next Year | $11.18 | $17.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 36.88 | 19.74 |
| 52 Week Low | $6.58 | $0.65 |
| 52 Week High | $13.30 | $4.94 |
| Indicator | BHM | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 38.36 | 18.07 |
| Support Level | N/A | N/A |
| Resistance Level | $8.55 | $2.18 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 37.71 | 12.93 |
Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.